SRC-3/AIB1: transcriptional coactivator in oncogenesis1
- 1 April 2006
- journal article
- review article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 27 (4), 387-394
- https://doi.org/10.1111/j.1745-7254.2006.00315.x
Abstract
APS (Acta Pharmacologica Sinica), the top pharmacology research journal based in China, publishes original articles and reviews on all aspects of pharmacology and the related life sciencesKeywords
This publication has 61 references indexed in Scilit:
- The Nuclear Receptor Coactivator AIB1 Mediates Insulin-like Growth Factor I-induced Phenotypic Changes in Human Breast Cancer CellsCancer Research, 2004
- Overexpression of the Nuclear Receptor Coactivator AIB1 ( SRC-3 ) during Progression of Pancreatic AdenocarcinomaClinical Cancer Research, 2004
- The Transcriptional Co-activator p/CIP (NCoA-3) Is Up-regulated by STAT6 and Serves as a Positive Regulator of Transcriptional Activation by STAT6Published by Elsevier ,2004
- Role of the Steroid Receptor Coactivator SRC-3 in Cell GrowthMolecular and Cellular Biology, 2003
- Interleukin-6 Is an Autocrine Growth Factor in Human Prostate CancerThe American Journal of Pathology, 2001
- Ribozyme Targeting Demonstrates That the Nuclear Receptor Coactivator AIB1 Is a Rate-limiting Factor for Estrogen-dependent Growth of Human MCF-7 Breast Cancer CellsJournal of Biological Chemistry, 2001
- RAC‐3 is a NF‐κB coactivatorFEBS Letters, 2000
- Regulation of Transcription by a Protein MethyltransferaseScience, 1999
- AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian CancerScience, 1997
- Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence beta-casein gene expressionMolecular Endocrinology, 1995